These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22271297)

  • 1. CYP2A6 genetic variation and dexmedetomidine disposition.
    Kohli U; Pandharipande P; Muszkat M; Sofowora GG; Friedman EA; Scheinin M; Wood AJ; Ely EW; Tyndale RF; Choi L; Stein CM; Kurnik D
    Eur J Clin Pharmacol; 2012 Jun; 68(6):937-42. PubMed ID: 22271297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study.
    Choi L; Caffo BS; Kohli U; Pandharipande P; Kurnik D; Ely EW; Stein CM
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):613-36. PubMed ID: 21847635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CYP2A6 gene polymorphism on the pharmacokinetics of dexmedetomidine for premedication.
    Wang L; Wang S; Qi J; Yu R; Zhuang J; Zhuang B; Lou Y; Ruan J; Ye H; Lin F
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):917-922. PubMed ID: 30092666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.
    Djordjevic N; Carrillo JA; van den Broek MP; Kishikawa J; Roh HK; Bertilsson L; Aklillu E
    Drug Metab Pharmacokinet; 2013; 28(2):93-7. PubMed ID: 22850738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
    Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
    Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large inter-individual variability in pharmacokinetics of dexmedetomidine and its two major N-glucuronides in adult intensive care unit patients.
    Yang M; Tse AHW; Lee A; Joynt GM; Zuo Z
    J Pharm Biomed Anal; 2019 Oct; 175():112777. PubMed ID: 31362246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.
    Djordjevic N; Carrillo JA; Gervasini G; Jankovic S; Aklillu E
    Eur J Clin Pharmacol; 2010 Jun; 66(6):571-8. PubMed ID: 20155256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors.
    Wiczling P; Bartkowska-Śniatkowska A; Szerkus O; Siluk D; Rosada-Kurasińska J; Warzybok J; Borsuk A; Kaliszan R; Grześkowiak E; Bienert A
    J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):315-24. PubMed ID: 27221375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.
    Swan GE; Benowitz NL; Lessov CN; Jacob P; Tyndale RF; Wilhelmsen K
    Pharmacogenet Genomics; 2005 Feb; 15(2):115-25. PubMed ID: 15861035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
    Nakajima M; Kuroiwa Y; Yokoi T
    Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.
    Satarug S; Tassaneeyakul W; Na-Bangchang K; Cashman JR; Moore MR
    Curr Clin Pharmacol; 2006 Sep; 1(3):291-309. PubMed ID: 18666753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.
    Mahavorasirikul W; Tassaneeyakul W; Satarug S; Reungweerayut R; Na-Bangchang C; Na-Bangchang K
    Eur J Clin Pharmacol; 2009 Apr; 65(4):377-84. PubMed ID: 19082995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpine.
    Endo T; Nakajima M; Fukami T; Hara Y; Hasunuma T; Yokoi T; Momose Y
    Pharmacogenet Genomics; 2008 Sep; 18(9):761-72. PubMed ID: 18698229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
    Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
    Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedative Plasma Concentrations and Delirium Risk in Critical Illness.
    Stollings JL; Thompson JL; Ferrell BA; Scheinin M; Wilkinson GR; Hughes CG; Shintani AK; Ely EW; Girard TD; Pandharipande PP; Patel MB
    Ann Pharmacother; 2018 Jun; 52(6):513-521. PubMed ID: 29363356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.
    Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T
    Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.